Acute Neurologic Emergencies

SECTION 1

Historical Context & Motivation

The management of acute neurologic emergencies has evolved dramatically over the past century, transforming from largely observational and palliative approaches to highly protocolized, evidence-based interventions where minutes determine outcomes. For much of the nineteenth and early twentieth centuries, conditions such as stroke, status epilepticus, and acute spinal cord compression carried near-universal devastating prognoses because clinicians lacked both the diagnostic tools and the therapeutic armamentarium to intervene effectively. The concept that the brain could be rescued from ongoing injury—rather than merely observed in its decline—fundamentally reshaped neurology and emergency medicine.

The modern era of neurologic emergency medicine is defined by the recognition that neural tissue is exquisitely sensitive to ischemia, that salvageable penumbral zones exist around irreversibly damaged cores, and that time-to-treatment is the single most critical variable in determining functional outcome. This principle—often encapsulated in the phrase "time is brain"—serves as the organizing framework for contemporary emergency neurology and is a major focus of USMLE Step 2 examination questions.

1906

Cajal's Neuron Doctrine

Santiago Ramón y Cajal receives the Nobel Prize, establishing the neuron as the functional unit of the nervous system and laying the groundwork for understanding focal neurologic deficits.

1971

CT Scanning Revolutionizes Diagnosis

Godfrey Hounsfield introduces computed tomography, enabling rapid differentiation of ischemic from hemorrhagic stroke for the first time—a distinction essential for treatment decisions.

1995

NINDS rt-PA Stroke Trial

The landmark NINDS trial demonstrates that intravenous alteplase administered within 3 hours of ischemic stroke onset significantly improves functional outcomes, establishing the modern thrombolytic era.

2015

Endovascular Thrombectomy Trials

Five major randomized controlled trials (MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, REVASCAT) demonstrate the superiority of mechanical thrombectomy for large vessel occlusion stroke, extending the treatment window.

2018

DAWN & DEFUSE-3 Expand the Window

Trials using perfusion imaging demonstrate that select patients benefit from thrombectomy up to 24 hours after symptom onset, ushering in the era of tissue-based (rather than purely time-based) patient selection.

These historical advances converge on a central clinical question that underlies every acute neurologic emergency: How do we identify, localize, and intervene upon life-threatening neurologic injury in the shortest possible time? Mastering this question requires a systematic approach to the major categories of neurologic emergencies—stroke, status epilepticus, elevated intracranial pressure, acute spinal cord compression, meningitis/encephalitis, and neuromuscular respiratory failure—each of which is explored in depth throughout this lesson.

SECTION 2

Core Principles & Definitions

Acute neurologic emergencies share a common pathophysiologic thread: neural tissue is under imminent threat of irreversible injury, and timely intervention can modify the trajectory from permanent disability toward functional recovery. The foundational principles that guide the clinician through these scenarios are rooted in neuroanatomic localization, rapid diagnostic algorithms, and protocolized treatment pathways. Before addressing individual conditions, it is essential to internalize the overarching concepts that unify the field.

Time Is Brain

In ischemic stroke, approximately 1.9 million neurons are lost per minute of untreated large vessel occlusion. Every acute neurologic emergency has a critical treatment window beyond which intervention offers diminishing or no returns.

Localize Before You Treat

Neuroanatomic localization—determining whether the lesion is cortical, subcortical, brainstem, spinal, or peripheral—dictates the differential diagnosis and urgency of imaging. The neurologic examination remains the most powerful localizing tool.

ABCs Then Neurology

Airway, breathing, and circulation stabilization precedes neurologic workup. Conditions like Guillain-Barré syndrome or myasthenic crisis threaten life through respiratory failure, not primary brain injury.

Ischemic Core vs. Penumbra

In stroke and other ischemic conditions, irreversibly damaged tissue (core) is surrounded by hypoperfused but salvageable tissue (penumbra). The goal of treatment is to rescue the penumbra before it converts to core infarct.

Herniation Is the Final Common Pathway

Elevated intracranial pressure (ICP) from mass lesions, edema, or hydrocephalus threatens brain herniation—the displacement of brain tissue across rigid intracranial compartments—which represents the ultimate neurologic emergency.

✦ KEY TAKEAWAY

Think of the brain during a neurologic emergency like a house on fire. The core infarct is the room already consumed by flames—it cannot be saved. The penumbra is the adjacent rooms filling with smoke but not yet ablaze—those can still be rescued if firefighters (treatment) arrive quickly. Every minute of delay means another room is lost. This analogy applies across nearly all acute neurologic emergencies: there is tissue at risk that can be salvaged only if the clinician acts within the narrow therapeutic window.

SECTION 3

Visual Explanation — Acute Stroke Algorithm

Acute ischemic stroke represents the prototypical neurologic emergency, and its management algorithm illustrates the systematic, time-driven decision-making that characterizes all conditions in this domain. The following diagram traces the evaluation pathway from emergency department arrival through definitive treatment, emphasizing the critical decision nodes that determine patient management. Understanding this flowchart is essential for USMLE Step 2, where stroke questions frequently present clinical vignettes requiring the examinee to identify the next best step in management.

Acute stroke evaluation algorithm. The initial branch point is the non-contrast CT head, which separates hemorrhagic from ischemic stroke. For ischemic stroke, time from onset and presence of large vessel occlusion (LVO) on CT angiography determine eligibility for IV thrombolysis and/or mechanical thrombectomy.

Notice that the algorithm begins with stabilization (ABCs and glucose), proceeds immediately to imaging, and then branches based on whether hemorrhage is present. The non-contrast CT head is the pivotal diagnostic study because IV thrombolysis is absolutely contraindicated in hemorrhagic stroke, and the CT can be obtained and interpreted within minutes. For ischemic stroke, the two principal reperfusion strategies—IV alteplase (within 4.5 hours) and mechanical thrombectomy (up to 24 hours for selected patients with favorable perfusion imaging)—are not mutually exclusive. In fact, eligible patients should receive alteplase and then proceed to the angiography suite for thrombectomy if a large vessel occlusion is confirmed. The stated time targets—door-to-CT ≤ 25 minutes, door-to-needle ≤ 60 minutes, and door-to-groin puncture ≤ 90 minutes—are performance benchmarks that should be committed to memory.

SECTION 4

Pathophysiologic Mechanisms

Ischemic Cascade and the Penumbra Model

When cerebral blood flow (CBF) drops below critical thresholds, a predictable cascade of cellular events ensues. Normal CBF is approximately 50 mL/100 g/min. When CBF falls below approximately 20 mL/100 g/min, neuronal electrical function ceases (producing clinical symptoms), but the cells remain structurally intact—this is the ischemic penumbra. When CBF drops below approximately 10 mL/100 g/min, membrane integrity is lost, leading to irreversible cell death—the ischemic core. The therapeutic window exists because penumbral tissue can survive for hours through collateral perfusion, but it progressively converts to core infarct without reperfusion.

NEURONAL LOSS RATE

~1.9 × 10⁶ neurons lost per minute of untreated LVO

This estimate, derived from the work of Saver (2006), underscores the urgency: every 15-minute delay in reperfusion results in measurably worse functional outcomes at 90 days.

Intracranial Pressure Dynamics

The Monro-Kellie doctrine states that the intracranial compartment is a fixed volume composed of three components: brain parenchyma (~80%), cerebrospinal fluid (~10%), and blood (~10%). An increase in the volume of any one component must be compensated by a decrease in another, or intracranial pressure (ICP) will rise. This principle is critical for understanding why mass lesions (tumors, hemorrhages, abscesses) and diffuse cerebral edema produce herniation syndromes.

MONRO-KELLIE DOCTRINE

V_brain + V_CSF + V_blood = V_total (constant)

V_brain = volume of brain parenchyma; V_CSF = volume of cerebrospinal fluid; V_blood = volume of intracranial blood. When a mass lesion (e.g., epidural hematoma) increases V_blood, compensatory mechanisms first displace CSF and then venous blood. Once these mechanisms are exhausted, ICP rises exponentially.

CEREBRAL PERFUSION PRESSURE

CPP = MAP − ICP

CPP = cerebral perfusion pressure; MAP = mean arterial pressure; ICP = intracranial pressure. Normal CPP is 60–70 mmHg. When ICP rises (from hemorrhage, edema, or hydrocephalus), CPP falls, potentially causing secondary ischemic injury. The goal of ICP management is to maintain CPP > 60 mmHg.

Status Epilepticus: Excitotoxicity

In status epilepticus—defined as continuous seizure activity lasting ≥ 5 minutes or ≥ 2 discrete seizures without return to baseline—the mechanism of injury shifts from purely ischemic to excitotoxic. Sustained glutamate release activates NMDA receptors, causing massive calcium influx that triggers mitochondrial dysfunction, free radical generation, and neuronal death. Concurrently, GABA_A receptor internalization progressively renders benzodiazepines less effective, which is why early treatment with benzodiazepines is critical—the longer the delay, the more refractory the seizures become. This self-reinforcing cycle explains the stepwise escalation from first-line benzodiazepines to second-line antiepileptic drugs and ultimately to continuous infusion anesthetics.

SECTION 5

Classification of Acute Neurologic Emergencies

A systematic classification of acute neurologic emergencies organizes conditions by the primary site and mechanism of injury, facilitating rapid differential diagnosis and treatment selection. The following diagram and table present the major categories with their defining features, key diagnostic studies, and time-critical interventions.

Classification tree of major acute neurologic emergencies. The three primary branches—cerebrovascular, seizure/epilepsy, and infectious/inflammatory—are supplemented by additional categories including elevated ICP/herniation, spinal cord compression, and neuromuscular respiratory failure.

Summary of major acute neurologic emergencies with their diagnostic workup, time-critical interventions, and therapeutic windows

Emergency	Key Diagnostic Study	Critical Intervention	Time Window
Ischemic Stroke	NCCT → CTA → CT perfusion	IV alteplase ± thrombectomy	tPA ≤ 4.5 h; thrombectomy ≤ 24 h
Hemorrhagic Stroke (ICH)	NCCT head	BP control (SBP < 140); reverse anticoagulation	Immediate
SAH	NCCT → LP if CT negative → CTA	Secure aneurysm (clip or coil); nimodipine	Within 24–72 h
Status Epilepticus	EEG (continuous); labs; CT/MRI	IV lorazepam → fosphenytoin/levetiracetam → infusion	BZD within 5 min
Bacterial Meningitis	LP (CSF analysis); blood cultures	Empiric ceftriaxone + vancomycin + dexamethasone	ABx within 60 min (do NOT delay for LP)
HSV Encephalitis	MRI brain; LP with HSV PCR	IV acyclovir empirically	Start immediately if suspected
Spinal Cord Compression	MRI whole spine (emergent)	IV dexamethasone → surgery or radiation	Within hours (before paralysis becomes permanent)
GBS / Myasthenic Crisis	FVC monitoring; NCS/EMG; LP	IVIG or plasmapheresis; intubate if FVC < 20 mL/kg	Serial monitoring; intubate before respiratory failure

SECTION 6

Worked Example — Acute Ischemic Stroke Presentation

The following clinical vignette walks through the step-by-step approach to a patient presenting with an acute neurologic emergency. This example mirrors the format and complexity of USMLE Step 2 CK questions and illustrates the systematic thought process required for rapid, accurate clinical decision-making.

🏥 CLINICAL VIGNETTE

A 68-year-old woman with a history of atrial fibrillation (not on anticoagulation) is brought to the emergency department by EMS 90 minutes after her husband witnessed the sudden onset of right-sided weakness and inability to speak. Her vital signs are: BP 185/100 mmHg, HR 88 (irregularly irregular), RR 16, SpO₂ 97% on room air. On examination, she has a right gaze preference, global aphasia, right-sided hemiplegia, and right hemineglect. Her NIHSS score is 19. A stat non-contrast CT head shows no hemorrhage. What is the next best step in management?

Step-by-Step Clinical Reasoning

Step 1 — Recognize the SyndromeThe acute onset of right-sided hemiplegia, global aphasia, gaze preference, and hemineglect in an elderly patient with atrial fibrillation is classic for a left middle cerebral artery (MCA) territory stroke due to cardioembolism. The NIHSS of 19 indicates a severe deficit, strongly suggestive of a large vessel occlusion (LVO).

Left MCA territory ischemic stroke, likely LVO from cardioembolic source

Step 2 — Confirm Eligibility for IV ThrombolysisThe patient is within the 4.5-hour window for IV alteplase (90 minutes from witnessed onset). The CT head shows no hemorrhage, which is the essential prerequisite. She has no absolute contraindications (no recent surgery, no active bleeding, no prior intracranial hemorrhage, no platelet count concerns mentioned). The BP of 185/100 must be lowered to < 185/110 before alteplase administration—this is typically achieved with IV labetalol or nicardipine.

Eligible for IV alteplase: within window, no hemorrhage on CT, no contraindications

Step 3 — Administer IV AlteplaseIV alteplase is dosed at 0.9 mg/kg (maximum 90 mg), with 10% given as a bolus over 1 minute and the remainder infused over 60 minutes. The door-to-needle target is ≤ 60 minutes. During the infusion, the patient should have frequent neurologic checks and BP monitoring. Anticoagulants and antiplatelets are held for 24 hours after alteplase.

Administer IV alteplase 0.9 mg/kg (10% bolus, 90% over 60 min)

Step 4 — Evaluate for Mechanical ThrombectomyGiven the high NIHSS (≥ 6), strong clinical suspicion for LVO, and presentation within 6 hours, CT angiography (CTA) of the head and neck should be obtained concurrently to evaluate for a proximal large vessel occlusion (internal carotid artery or M1 segment of MCA). If confirmed, the patient should be taken emergently for endovascular mechanical thrombectomy. Alteplase should NOT be delayed while awaiting CTA results—both treatments can be pursued in parallel.

Obtain CTA concurrently; proceed to thrombectomy if LVO confirmed

Step 5 — Post-Treatment ManagementAdmit to a stroke unit or neuro-ICU for continuous monitoring. Maintain BP < 180/105 for 24 hours post-tPA. Obtain repeat CT head at 24 hours before initiating anticoagulation for atrial fibrillation. Perform a dysphagia screen before oral intake. Initiate DVT prophylaxis. The long-term plan includes anticoagulation (e.g., apixaban) for secondary stroke prevention given the atrial fibrillation etiology.

Stroke unit admission → repeat CT at 24 h → initiate anticoagulation for AF

SECTION 7

Stroke Subtypes — Key Differentiators

One of the most critical distinctions in acute neurology is differentiating between ischemic stroke, intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH), as the management pathways diverge sharply. USMLE Step 2 frequently tests the ability to distinguish these entities based on clinical presentation and imaging findings. The table below synthesizes the key features of each stroke subtype.

Comparison of the three major stroke subtypes

Feature	Ischemic Stroke	Intracerebral Hemorrhage	Subarachnoid Hemorrhage
Onset	Sudden; maximal deficit at onset or stepwise	Sudden; often progressive over minutes to hours	"Thunderclap" headache — worst headache of life
Risk Factors	AF, carotid stenosis, diabetes, HTN, hyperlipidemia	Chronic HTN (#1), anticoagulation, amyloid angiopathy	Saccular (berry) aneurysm, AVM, cocaine use
Exam Findings	Focal deficits corresponding to vascular territory	Focal deficits + signs of elevated ICP (vomiting, decreased LOC)	Meningismus, photophobia, CN III palsy (PCA aneurysm)
CT Head	Often normal early (< 6 h); may show hyperdense vessel sign	Hyperdense (white) intraparenchymal lesion	Hyperdensity in subarachnoid space/cisterns; ~95% sensitive within 6 h
Management	IV tPA ± thrombectomy; permissive HTN (< 220/120 if no tPA)	Aggressive BP lowering (SBP < 140); reverse anticoagulation; neurosurgery consult	Secure aneurysm (endovascular coiling preferred); nimodipine for vasospasm; EVD if hydrocephalus
Key Complication	Hemorrhagic transformation (especially after tPA)	Hematoma expansion; herniation	Vasospasm (days 4–14); rebleeding; hydrocephalus

💡 HIGH-YIELD PEARL

The single most important initial step in any stroke presentation is the non-contrast CT head. Its purpose is NOT to diagnose ischemic stroke (which is often CT-negative early) but to exclude hemorrhage so that thrombolysis can be safely administered. Think of it as a "permission slip" for tPA, not as a diagnostic test for ischemia. For SAH specifically, if the CT is negative but clinical suspicion is high, a lumbar puncture looking for xanthochromia is the next step—this is one of the most commonly tested sequences on USMLE.

SECTION 8

Advanced Concepts — Herniation Syndromes & Status Epilepticus Protocols

Herniation Syndromes

Understanding brain herniation syndromes is essential for recognizing when a patient's neurologic emergency has reached its most critical phase. Herniation occurs when rising intracranial pressure forces brain tissue across rigid dural or bony boundaries, compressing vital structures. The most clinically important types are uncal (transtentorial), central (downward), subfalcine, and tonsillar herniation. Each produces a characteristic clinical syndrome that the clinician must recognize immediately.

Herniation syndromes with clinical presentations and emergency management

Herniation Type	Mechanism	Classic Signs	Emergency Intervention
Uncal (Transtentorial)	Temporal lobe mass pushes uncus over the tentorium cerebelli	Ipsilateral CN III palsy ("blown pupil"), contralateral hemiparesis, decreased LOC	Mannitol or 23.4% NaCl; emergent surgical decompression
Central (Downward)	Bilateral hemispheric swelling pushes diencephalon downward	Bilateral small reactive pupils → bilateral fixed dilated; progressive coma; Cushing triad (HTN, bradycardia, irregular breathing)	Osmotic therapy; consider decompressive craniectomy
Subfalcine	Cingulate gyrus herniates under the falx cerebri	Contralateral leg weakness (ACA compression); often precedes uncal herniation	Treat underlying mass effect
Tonsillar	Cerebellar tonsils herniate through the foramen magnum	Cardiorespiratory arrest (brainstem compression); neck stiffness; sudden death	Suboccipital decompressive craniectomy; EVD for hydrocephalus

Status Epilepticus Treatment Protocol

The management of status epilepticus follows a strict time-based protocol that escalates through three tiers of therapy. Understanding this stepwise approach and its rationale is a frequent USMLE testing point. The protocol reflects the progressive loss of GABA_A receptor surface expression that renders benzodiazepines increasingly ineffective with time.

Status Epilepticus Treatment Timeline

1st Line: IV Lorazepam (0.1 mg/kg)

2nd Line: Fosphenytoin or Levetiracetam

3rd Line: Continuous Infusion (Midazolam/Propofol/Pentobarbital)

0 min

5 min

20 min

40+ min

Seizure OnsetRefractory SE

⚠️ USMLE HIGH-YIELD

Key board-testable points: (1) Benzodiazepines are always first-line—IV lorazepam is preferred for established access; IM midazolam if no IV access. (2) Do NOT delay benzodiazepines to obtain imaging. (3) Always check glucose—hypoglycemia is a reversible cause of seizures. (4) Phenytoin/fosphenytoin is contraindicated in seizures caused by alcohol withdrawal or benzodiazepine withdrawal.

SECTION 9

Practice Problems

PROBLEM 1 — CONCEPTUAL

A 72-year-old man presents to the ED with sudden-onset left-sided weakness and dysarthria that began 2 hours ago. His wife states that he takes warfarin for atrial fibrillation. What is the single most important initial imaging study, and what is its primary purpose in this clinical context?

PROBLEM 2 — BASIC CALCULATION

A 55-year-old woman weighing 70 kg presents with an acute ischemic stroke and is eligible for IV alteplase. Calculate the total dose, bolus dose, and infusion dose. Recall that alteplase is dosed at 0.9 mg/kg (maximum 90 mg), with 10% given as a bolus and the remaining 90% infused over 60 minutes.

PROBLEM 3 — INTERMEDIATE

A 45-year-old woman presents with the sudden onset of the "worst headache of her life" while exercising. On examination, she has neck stiffness and photophobia but no focal neurologic deficits. A non-contrast CT head obtained 2 hours after symptom onset is read as normal. What is the next best step in management, and why?

PROBLEM 4 — APPLIED

A 60-year-old man with known metastatic lung cancer presents with acute bilateral lower extremity weakness, urinary retention, and a sensory level at T10. He reports back pain at the thoracolumbar junction that has been worsening over 3 days. On examination, he has bilateral lower extremity weakness (3/5), absent patellar and Achilles reflexes bilaterally, and decreased sensation below the umbilicus. Outline the immediate management steps, including the diagnosis you are most concerned about, the diagnostic study of choice, and the initial treatment.

PROBLEM 5 — CRITICAL THINKING

A 30-year-old woman is brought to the ED after being found unresponsive. On examination, she has a fixed, dilated left pupil, right hemiparesis, and decerebrate posturing on the right. Her GCS is 6 (E1V2M3). CT head reveals a large left-sided epidural hematoma with 12 mm of midline shift. Her neurosurgical team is 45 minutes away. Discuss the pathophysiology of her clinical findings (correlating each finding with the herniation anatomy), the temporizing medical measures you would initiate immediately, and the rationale for each.

SUMMARY

Summary — Acute Neurologic Emergencies

Acute neurologic emergencies are unified by the principle that time-to-treatment determines outcome. In ischemic stroke, the non-contrast CT head excludes hemorrhage to permit IV alteplase (≤ 4.5 hours) and mechanical thrombectomy (≤ 24 hours for LVO with favorable perfusion). Hemorrhagic stroke requires aggressive BP control and anticoagulation reversal, while subarachnoid hemorrhage demands aneurysm securing and nimodipine for vasospasm prevention. The Monro-Kellie doctrine explains why mass lesions cause herniation: the fixed intracranial volume means any expanding process must displace brain, CSF, or blood. Recognizing uncal herniation (ipsilateral blown pupil, contralateral hemiparesis) is critical for initiating osmotic therapy and surgical decompression.

In status epilepticus, the treatment escalation follows a strict protocol: benzodiazepines first (within 5 minutes), then second-line antiepileptic drugs, then continuous infusions for refractory cases—reflecting progressive GABA receptor internalization. Bacterial meningitis requires empiric antibiotics within 60 minutes—never delay antibiotics for LP or imaging. Spinal cord compression presents with bilateral weakness, a sensory level, and bladder dysfunction; it requires emergent MRI and IV dexamethasone. Finally, neuromuscular respiratory failure from Guillain-Barré syndrome or myasthenic crisis demands close monitoring of forced vital capacity (intubate if FVC < 20 mL/kg or < 1 L) and treatment with IVIG or plasmapheresis. Across all these conditions, the same systematic approach applies: stabilize, localize, image, and treat—rapidly and in parallel whenever possible.